This series provides guidance on the optimal management of HR+, HER2- metastatic breast cancer, and is designed for physicians, nurses, pharmacists, physician assistants and other members of the multidisciplinary cancer care team. The series provides an overview of first, second and third line therapies upon disease progression, as well as strategies for managing toxicities and enhancing quality of life for this patient population.

This session provides an overview of guideline development in the community setting for the utilization of BsAbs in patients.

This session provides an overview of the utilization of BsAbs in patients with follicular lymphoma.

This session provides an overview of the utilization of BsAbs in patients with diffuse large b-cell lymphomas

This session provides an overview of the utilization of BsAbs in patients with multiple myeloma.

This session provides an overview of the utilization of BsAbs in patients with cancer.

In this one-hour event, an expert panel of oncology care professionals discuss ways to identify ideal care recommendations for individuals with Stage IB-IIIA non-small cell lung cancer (NSCLC) amid rapidly advancing clinical data

Through this brief self-paced online eCourse, oncology professionals can better address the existing barriers to quality bladder cancer care for underserved populations and improve care coordination for improved health outcomes.

This webinar will provide an overview of the current insurance coverage landscape for CAR T-cell therapy. The discussion will focus on existing financial barriers and challenges that cancer programs face as they help patients and caregivers navigate CAR T-cell therapy.

Providing access to the latest CAR T-cell therapies is a key concern for professionals and patients in the community cancer setting. This webinar will explore what resources are required for establishing CAR T-cell therapy services in the community setting and how cancer programs and practices can prepare and budget for successful implementation.